CannaPharmaRX, Inc.
CPMD
$0.00
$0.00-4.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 87.15% | -71.25% | 110.31% | -- | 1,199.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 87.15% | -71.25% | 110.31% | -- | 1,199.61% |
| Cost of Revenue | 39.41% | -69.01% | 99.13% | 397.55% | 12.88% |
| Gross Profit | -7.58% | 68.37% | -89.28% | -262.43% | 29.85% |
| SG&A Expenses | -19.03% | 573.22% | 63.58% | -41.81% | -46.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.31% | -48.65% | 92.28% | 96.41% | -7.51% |
| Operating Income | -0.69% | 41.51% | -81.32% | -51.68% | 36.63% |
| Income Before Tax | 44.69% | -101.82% | -884.39% | -126.36% | 94.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.69% | -101.82% | -884.39% | -126.36% | 94.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.69% | -101.82% | -884.39% | -126.36% | 94.11% |
| EBIT | -0.69% | 41.51% | -81.32% | -51.68% | 36.63% |
| EBITDA | -0.69% | -- | -- | -73.15% | 35.23% |
| EPS Basic | 40.00% | -103.57% | -833.33% | -125.93% | 97.01% |
| Normalized Basic EPS | -133.33% | 17.14% | -800.00% | -120.31% | 105.43% |
| EPS Diluted | 40.00% | -103.57% | -833.33% | -125.93% | 97.01% |
| Normalized Diluted EPS | -133.33% | 17.14% | -800.00% | -120.31% | 105.43% |
| Average Basic Shares Outstanding | 1.10% | -0.04% | 0.00% | 0.69% | 89.01% |
| Average Diluted Shares Outstanding | 1.10% | -0.04% | 0.00% | 0.69% | 89.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |